[1]林丹桂,王海潮,杨林根,等.术前磁共振成像征象、超声弹性成像特征与乳腺癌患者人表皮生长因子受体2表达相关性研究[J].陕西医学杂志,2025,54(5):702-706,710.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.026]
　LIN Dangui,WANG Haichao,YANG Lingen,et al.Correlation between preoperative magnetic resonance imaging signs,ultrasonic elastography features and human epidermal growth factor receptor 2 expression in breast cancer patients[J].,2025,54(5):702-706,710.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.026]
点击复制

术前磁共振成像征象、超声弹性成像特征与乳腺癌患者人表皮生长因子受体2表达相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年5期
页码:
702-706,710
栏目:
临床病理
出版日期:
2025-05-05

文章信息/Info

Title:
Correlation between preoperative magnetic resonance imaging signs,ultrasonic elastography features and human epidermal growth factor receptor 2 expression in breast cancer patients
作者:
林丹桂; 王海潮; 杨林根; 林怀雄; 刘昌华
(解放军陆军第七十三集团军医院医学影像科,福建 厦门 361003)
Author(s):
LIN Dangui; WANG Haichao; YANG Lingen; LIN Huaixiong; LIU Changhua
(Department of Medical Imaging,the 73rd Group Army Hospital of the PLA Army,Xiamen 361003,China)
关键词:
乳腺癌;  人表皮生长因子受体2;  磁共振成像;  超声弹性成像;  预测价值;  相关性
Keywords:
Breast cancer;  Human epidermal growth factor receptor 2;  Magnetic resonance imaging;  Ultrasonic elastography;  Predictive value;  Correlation
分类号:
R 737.9
DOI:
DOI:10.3969/j.issn.1000-7377.2025.05.026
文献标志码:
A
摘要:
目的:探讨术前磁共振成像(MRI)征象、超声弹性成像特征与人表皮生长因子受体2(HER2)表达的相关性。方法:选取行手术治疗的乳腺癌患者228例,术前行MRI和超声弹性成像检查。收集患者癌组织和癌旁正常组织标本,免疫组织化学染色法检测组织中HER2表达,根据检测结果将患者分为HER2阳性组(160例)和HER2阴性组(68例)。采用多因素Logistic回归分析乳腺癌患者HER2阳性表达的影响因素。绘制受试者工作特征(ROC)曲线分析MRI征象和超声弹性成像特征对乳腺癌患者HER2阳性表达的预测价值。结果:两组患者在病灶形态、边缘方面比较差异有统计学意义(均P<0.05)。两组患者在强化方式、淋巴结转移、微钙化、边缘毛刺征、边缘分叶征、表观扩散系数(ADC)值方面比较差异有统计学意义(均P<0.05)。病灶形态不规则、非均匀强化、低ADC值、有淋巴结转移、微钙化、边缘毛刺征以及边缘分叶征是乳腺癌患者HER2阳性表达的独立危险因素(均P<0.05)。MRI征象和超声弹性成像特征(病灶形态、强化方式、淋巴结转移、微钙化、边缘毛刺征、边缘分叶征、ADC值)指标联合预测乳腺癌患者HER2阳性表达的曲线下面积(AUC)为0.879,高于各指标单独预测的AUC(均P<0.05)。结论:术前MRI征象、超声弹性成像特征与乳腺癌患者HER2阳性表达有关,采用MRI联合超声弹性成像检查对乳腺癌患者HER2阳性表达具有一定预测价值。
Abstract:
Objective:To investigate the correlation between preoperative magnetic resonance imaging(MRI)signs,ultrasonic elastography features and human epidermal growth factor receptor 2(HER2)expression in breast cancer patients.Methods:A total of 228 breast cancer patients undergoing surgical treatment were enrolled.All patients underwent MRI and ultrasonic elastography before surgery.Tumor and adjacent normal tissue samples were collected from the patients,and HER2 expression was detected by immunohistochemical staining.Patients were divided into HER2 positive group(160 cases)and HER2 negative group(68 cases)based on the detection results.Multivariate logistic regression analysis was used to identify the influencing factors of HER2 positive expression in breast cancer patients.Receiver operating characteristic(ROC)curves were plotted to analyze the predictive value of MRI signs and ultrasonic elastography features for HER2 positive expression in breast cancer patients.Results:There were significant differences between the two groups in terms of tumor shape and margin(all P<0.05).Significant differences were also observed between the two groups in enhancement pattern,lymph node metastasis,microcalcification,spiculated margin,lobulated margin and apparent diffusion coefficient(ADC)value(all P<0.05).Irregular tumor shape,spiculated margin,heterogeneous enhancement,low ADC value,lymph node metastasis,microcalcification,spiculated margin and lobulated margin were identified as independent risk factors for HER2 positive expression in breast cancer patients(all P<0.05).The combined prediction of HER2 positive expression in breast cancer patients using MRI signs and ultrasonic elastography features(tumor shape,margin,enhancement pattern,lymph node metastasis,microcalcification,spiculated margin,lobulated margin and ADC value)had an AUC of 0.879,which was higher than that of individual predictors(all P<0.05).Conclusion:Preoperative MRI signs and ultrasonic elastography features are correlated with HER2 positive expression in breast cancer patients.The combined use of MRI and ultrasonic elastography has predictive value for HER2 positive expression in breast cancer patients.

参考文献/References:

[1] TRAN A,NEZAMI N,KHORSHIDI F,et al.Development and management of iatrogenic biloma post microwave ablation of solitary metastatic breast cancer lesion in the liver[J].Radiol Case Rep,2024,20(1):151-157.
[2] ZHAO Y,CHEN X,WANG Y,et al.Stable or at least once HER2-low status during neoadjuvant chemotherapy confers survival benefit in patients with breast cancer[J].Ann Med,2024,56(1):2409343.
[3] 孙雪梅,苗佳贤,卜维航,等.HR阳性乳腺癌新辅助治疗后HER2阴性亚组蛋白水平表达的演变及与临床病理特征的相关性分析[J].临床与实验病理学杂志,2024,40(9):955-960,966.
[4] 李诗瑶,王薇,曹闲潭,等.超声造影和超声弹性成像特征与乳腺癌HER-2表达的相关性分析[J].中国医学装备,2024,21(5):69-73.
[5] 杨静茹,赵楠楠,张舒妮,等.多模态影像组学列线图在预测乳腺癌患者HER-2表达水平中的价值[J].临床放射学杂志,2024,43(9):1471-1477.
[6] 中国抗癌协会乳腺癌专业委员会,中华医学会肿瘤学分会乳腺肿瘤学组,邵志敏.中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J].中国癌症杂志,2023,33(12):1092-1186.
[7] 宋铁兵,李康乐,马强,等.土贝母皂苷甲对乳腺癌细胞MCF-7凋亡的影响[J].陕西中医,2023,44(11):1514-1517.
[8] 王志宇,胡玉蝶,洪时萃,等.乳腺癌“应激治乳”新理论的构建与临床应用探讨[J].广州中医药大学学报,2024,41(10):2547-2554.
[9] 林禹伯,卢柯羽,杨洋.染色体结构维持蛋白4在乳腺癌组织中的表达及其临床病理学意义[J].中国肿瘤生物治疗杂志,2024,31(9):888-894.
[10] SASAKI A,NAKAJIMA S,MOTOMURA Y.Exceptional response to pembrolizumab in HER2-positive gallbladder carcinoma with high tumor mutational burden[J].J Gastrointest Cancer,2024,55(4):1628-1633.
[11] KATO C,IIZUKA-OHASHI M,HONDA M,et al.Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer[J].Biochim Biophys Acta Mol Basis Dis,2024,1870(8):167458.
[12] NIMODIA D,KASHIKAR S V,PARIHAR P H,et al.Carotid body tumor imaging:MRI,ultrasound,and elastography with surgical management[J].Radiol Case Rep,2024,19(12):6085-6092.
[13] 毕伟培,石彦,王玲玲,等.超声造影联合剪切波弹性成像评估乳腺癌分子亚型的临床价值[J].中华全科医学,2023,21(12):2009-2013.
[14] 高宏,周立江,邢向荣,等.柴胡龙骨牡蛎汤加减治疗乳腺癌研究进展[J].陕西中医,2023,44(11):1657-1659.
[15] 郝鑫,胡崇珠,岳瑞雪,等.白蛋白结合型紫杉醇或多西他赛联合卡铂新辅助治疗HER2阳性乳腺癌疗效比较[J].肿瘤防治研究,2024,51(9):779-783.
[16] 赵晓萌,邵硕,郑宁,等.IVIM、DKI联合DCE-MRI的影像组学在预测乳腺癌HER-2表达状态中的应用价值[J].磁共振成像,2024,15(7):105-111.
[17] 尚怡研,王贇霞,郭亚欣,等.多参数MRI影像组学术前预测乳腺癌HER-2低表达的临床研究[J].临床放射学杂志,2024,43(8):1286-1291.
[18] 王正通,赵凡,李冲冲,等.磁共振成像与病理学多参数预测中晚期乳腺癌新辅助化疗疗效的价值[J].中国医师杂志,2024,26(9):1343-1349.
[19] 马长军,田士峰,宋庆玲,等.酰胺质子转移加权成像联合动态对比增强MRI定量参数术前评估子宫内膜癌人表皮生长因子受体2基因表达的价值[J].中华放射学杂志,2024,58(6):620-626.
[20] 刘磊,徐慧慧,王佳,等.乳腺MRI检查DWI、DCE-MRI定量参数与乳腺癌分子亚型及Ki-67表达的关系[J].河北医科大学学报,2024,45(7):779-784.
[21] 陈丽丽,施民新,薛丽娟.剪接因子3B亚单位1在乳腺癌组织中的表达及与患者临床病理特征关系[J].陕西医学杂志,2024,53(2):262-265.
[22] 邹腾跃,邹芳芳,孙亚君,等.烟酰胺磷酸核糖基转移酶及沉默信息调节因子2同源蛋白1在乳腺癌组织中的表达及与患者临床病理特征的关系[J].陕西医学杂志,2023,52(8):1093-1096,1101.
[23] 伊万萍,马志军,赵俊,等.多模态超声诊断不同分子分型乳腺癌与乳腺增生结节的价值[J].中国医学装备,2023,20(4):70-75.
[24] 陶鹏,侯岩,赵妩媚.超声弹性成像应变率比值在乳腺肿块鉴别中的应用及其与乳腺癌相关分子标记物的相关性[J].中国普通外科杂志,2022,31(11):1543-1547.
[25] 张辉,刘怀军,杨直堂,等.HER2基因突变对非小细胞肺癌临床特征及其与CT征象的相关性研究[J].现代生物医学进展,2020,20(24):4646-4650.

相似文献/References:

[1]乔亚舜,吴瑛琦.乳腔镜腋窝淋巴结清扫术治疗早期乳腺癌临床研究[J].陕西医学杂志,2019,(4):473.
　QIAO Yashun,WU Yingqi..Clinical study of mammoscopic axillary lymph node dissection for early breast cancer patients[J].,2019,(5):473.
[2]谭兴利,陆伟辉,汤学文,等.乳腺癌患者超声检查中PSV、RI值与术后组织中MMP11、VEGF表达的相关性探讨[J].陕西医学杂志,2019,(5):617.
[3]韩丕华,宋张骏△,杨晓民,等.乳腺超声造影联合细针穿刺定位活检在判定乳腺癌新辅助化疗后腋窝淋巴结性质中的临床研究*[J].陕西医学杂志,2019,(7):842.
　HAN Pihua,SONG Zhangjun,YANG Xiaomin,et al.Application of breast contrast-enhanced ultrasonography combined with fine needle aspiration biopsy in determining the axillary lymph node properties after neoadjuvant chemotherapy for breast cancer[J].,2019,(5):842.
[4]蒋 敢,王 军,王会东△.舒芬太尼联合罗哌卡因肋间神经阻滞对乳腺癌患者术后镇痛、免疫功能及应激反应的影响*[J].陕西医学杂志,2019,(8):1077.
　JIANG Gan,WANG Jun,WANG Huidong..Effect of sufentanil plus ropivacaine intercostal nerve block on postoperative analgesia, immunity and stress response in patients with breast cancer[J].,2019,(5):1077.
[5]王群拴,黎小花△.核磁共振结合血清肿瘤标志物及细胞因子检测在〖JZ〗乳腺癌诊断中的应用价值研究*[J].陕西医学杂志,2019,(10):1295.
[6]韩丕华,袁 权△.乳腺癌患者白细胞介素-22表达水平对新辅助化疗后病理学完全缓解的预测价值*[J].陕西医学杂志,2020,49(7):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
　HAN Pihua,YUAN Quan..Predictive value of IL-22 expression level in breast cancer patients for pathological complete remission after neoadjuvant chemotherapy[J].,2020,49(5):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
[7]韩金怡,苏志勇.21基因检测对早期Luminal A型乳腺癌治疗指导作用研究[J].陕西医学杂志,2021,50(9):1081.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.010]
　HAN Jinyi,SU Zhiyong.Guiding role of 21-gene detection in treatment of early Luminal type A breast cancer[J].,2021,50(5):1081.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.010]
[8]白玲娇,陈小军,王 婷.乳腺癌超声弹性成像评分与免疫组化指标表达水平相关性分析[J].陕西医学杂志,2021,50(10):1239.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.015]
[9]郑 超,苏 娟,盛杰鑫,等.乳腺癌患者病灶血流时间-信号强度曲线类型、表观弥散系数与化疗疗效相关性分析[J].陕西医学杂志,2021,50(12):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
　ZHENG Chao,SU Juan,SHENG Jiexin,et al.Correlation between focal blood flow time-signal intensity curve type,apparent diffusion coefficient and chemotherapy efficacy in breast cancer patients[J].,2021,50(5):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
[10]李福平,王 茂,邱春丽,等.莱菔硫烷联合维生素D对乳腺癌细胞增殖及凋亡的影响[J].陕西医学杂志,2022,51(8):916.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.003]
　LI Fuping,WANG Mao,QIU Chunli,et al.Effect of sulforaphane combined with vitamin D on proliferation and apoptosis of breast cancer cells[J].,2022,51(5):916.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.003]

备注/Memo

备注/Memo:
[基金项目]福建省卫生健康委员会医学科学研究计划项目(20221639)
更新日期/Last Update: 2025-05-05